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Hemophilia is an hereditary coagulopathy linked to X-chromosome which mainly affects male individuals.^[@ref1]^ It can be either hemophilia A or B depending whether there is a decrease of factor VIII or IX. It has an incidence of 1 per 5000 male births.^[@ref2]^ Hemophilia A is the most common type accounting for 85% of the cases.^[@ref2]^ It is suspected by an unexpected bleeding event with isolated prolonged activated partial thromboplastin time (APTT) on coagulation studies.^[@ref3]^ The diagnosis is made by decreased plasmatic factor VIII or IX activity, after testing other coagulation factors (including von Willebrand factor).^[@ref4]^ Its severity depends on the factor activity and correlates with clinical features, being severe hemophilia a significant risk for spontaneous bleeding,^[@ref2]^ and cranial hemorrhage (3.5 to 4% of hemophilic patients).^[@ref5]^ After diagnosis of hemophilia, treatment for acute bleeding should be undertaken urgently with FVIII or FIX concentrates. Despite being an hereditary condition it has a significant rate of *de novo* mutations, which could go from 30 to 50%.^[@ref1],[@ref6]^ Nowadays, major hemophilia problems are life-threatening bleeding and inhibitor development.^[@ref7]^

When there is known family history, usually the diagnosis is made during the neonatal period.^[@ref8]^ A significant hemostatic challenge like surgery, major trauma or labor, can represent a high bleeding risk.^[@ref6],[@ref9],[@ref10]^ Neonatal hemophilia presentation is usually either related to a traumatic labor (intracranial hemorrhage and cephalohematoma) or to iatrogenic bleeding during heel stab sampling, venous puncture or vitamin K administration.^[@ref3]^ Rarely neonatal hemophilia presents with subgaleal hemorrhage and it carries a high mortality risk due to severe bleeding.^[@ref11]^ Hemophilic patients may remain undiagnosed during neonatal period.^[@ref6]^ Better treatment strategies centered on recombinant factors replacement lead to a considerable decrease on mortality rates for hemophilia in last years, with recent studies showing a nearly normal life expectancy even in severe hemophilia.^[@ref12],[@ref13]^ Our aim is to describe an unknown severe hemophilia in a neonate presenting a subgaleal hemorrhage.

Case Report {#sec1-2}
===========

Male, black newborn, with healthy and unrelated parents, and no known hereditary or hematological conditions. All obstetric workup was normal. The current gestation was uncomplicated, with a vaginal delivery at 39 weeks, with no complications. At first exam he had an Apgar index of 9 at first minute and 10 at five minutes. Birth weight of 3840 grams (heavy for gestational age), height: 50.5 cm and head circumference: 35 cm. No dimorphism detected and there were no traumatic lesions. He was transferred with his mother to obstetrics ward for regular neonatal care. Vitamin K was administered at birth and breastfeeding was started. At 52 hours of life he was urgently assessed for marked pallor and severe palpebral edema. At physical examination he presented with scarcely active, with low pitched crying, poor perfusion, heart rate of 135 bpp, normal blood pressure (81/47 mmHg), normal oxygen saturation, with normal pulmonary and cardiac examination. He had marked irregular scalp edema with a retro auricular hematoma. There was a 4 cm increase on head circumference (39 cm). There were no other changes on physical examination, namely signs of hemorrhagic diathesis. No history of trauma or fall. He was transferred to neonatal intensive care unit and a full blood count, coagulation study, blood chemistry and blood culture were performed. The blood count was consistent with severe anemia (hemoglobin: 6.6 g/dL) and coagulation studies revealed a prolonged APTT and a pro-thrombin time not coagulable, interpreted as an inadequate sample which was repeated to show an isolated prolonged APTT. Factor VIII, IX, XIII and vWF were measured, with a very low factor VIII activity (\<1%) which was compatible with severe hemophilia. Blood chemistry was unremarkable at first with a steady increase in indirect bilirubin.

Cerebral ultrasound at day 1 showed enlarged pericerebral space, with a bad differentiation of structures, with no apparent intracranial hemorrhage. Head computed tomography (CT) scan showed extensive bilateral subgaleal hematomas and no images compatible with intracranial bleeding. It also showed no signs of cranial fractures. Meantime he started saline bolus (20 mL/kg), erythrocyte transfusion (15 mL/kg), intravenous vitamin K and adequate analgesia.

After the diagnosis, recombinant factor VIII concentrate (50 IU/Kg) was started. There was no further progression of the subgaleal bleeding with slow decrease in head circumference. He kept hemodynamic and cardio-respiratory stability. He was under phototherapy for jaundice during 72 hours (maximum of 18.4 mg/dL total bilirubin).

He was discharged on day 11 of life with a resolving subgaleal hemorrhage, head circumference of 36.8 cm. He was referred to both neonatology and hematology follow up clinics. Since discharge he had 2 minor bleeding episodes (thoracic wall and right knee subcutaneous hematomas) requiring a single dose of factor VIII at each event. He will start FVIII prophylaxis after the first hemarthroses.

Currently he is 8 months old and had no further clinical relevant complications up to date.
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This case shows a severe subgaleal hemorrhage as a presentation of a severe hemophilia. Despite hemophilia being a known risk factor for cranial bleeding, we found no record of a similar presentation after an uncomplicated vaginal delivery and with no traumatic history or family history of coagulopathy. Our patient presented with anemia, lethargy and pre-shock, the most common presentation in hemophilic patients with cranial bleeding.^[@ref5]^ He had a severe subgaleal hemorrhage with an increase in 4 cm on head circumference and jaundice and required a saline bolus and packed red cells transfusion.^[@ref14]^ According to Plauché *et al*., 1 cm increase on head size can relate to at least 40 mL bleeding.^[@ref15],[@ref16]^ If we bare in mind that the total circulating blood of a neonate is around 80 mL/kg a 4 cm increase on head size represents at least a blood loss of 160 mL bleed (52% of total volume).^[@ref17]^ According to literature, coagulation studies should be made as soon as possible under a suspicion of consumption coagulopathy.^[@ref18]^ When present, disseminated intravascular coagulopathy seems to represent a sign of poor prognosis.^[@ref19]^

We focused our approach on aggressive correction of hypovolemic shock with saline bolus and red cell transfusion, according to the existent literature.^[@ref20]^ Inotropes and vasopressors may also be used.

High mortality rates of subgaleal hemorrhage are related to delays on diagnosis, misdiagnosis and inadequate monitoring and treatment.^[@ref18]^ So early recognition, careful monitoring and aggressive treatment were important to improve outcome.

As recommended by literature head imaging with a CT scan was made as soon as possible to assess the size of bleeding and related complications or co-morbidities.^[@ref18]^ Head magnetic resonance would be the preferred imaging method,^[@ref18]^ but was not promptly available.

Complications related to subgaleal hemorrhage and hypoxic ischemic encephalopathy can complicate up to 72% of the cases.^[@ref14]^ Development delay and cerebral palsy are the main complications,^[@ref18]^ however outcome of survivors is usually good, with a maximum described disability incidence of 33%.^[@ref19]^ At this moment our patient shows a normal development.

In severe hemophilia, the prevention of bleeding by prophylactic therapy is now advocated. The optimal treatment regimen for prophylaxis is debatable (when to start and which dose). Long term treatment strategies for hemophilia vary, with more studies suggesting a prophylactic treatment for severe cases of hemophilia A and an on demand treatment should be considered for mild and moderate cases.^[@ref4]^ Most of these studies are not conducted on neonates and small children for whom there is scarce information about the ideal treatment plan. According to the hematology department we decided to maintain our patient with on demand treatment, until the first hemarthroses.

Conclusions {#sec1-4}
===========

After reviewing existent literature we conclude that our patient had a rare presentation of hemophilia. He presented a subgaleal hemorrhage after an uncomplicated vaginal delivery. Aggressive support treatment was effective on controlling initial bleeding and preventing shock. Hemophilia diagnosis was made within 12 hours after presentation and treatment towards hemophilia A started, with no other bleeding episodes during inpatient stay. Imaging studies showed no other complications from the initial presentation and a normal neurodevelopment was achieved up to date. This case report reminds that hemophilia can present in several different ways. When facing a significant bleeding on a neonate with no risk factors, a blood coagulation disorder must be thought along with immediate aggressive support measures. An early diagnosis allows to an early directed treatment and better outcome.
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